New hope for Tough-to-Treat breast cancer
Disease control
Recruiting now
This study is testing whether an experimental drug called tenalisib can help control metastatic triple-negative breast cancer. It's for patients who have already tried 1-3 other treatments that didn't work well enough. Researchers will measure how many patients benefit from the d…
Phase: PHASE2 • Sponsor: Rhizen Pharmaceuticals SA • Aim: Disease control
Last updated Apr 02, 2026 02:12 UTC